Search bioRxiv⌕ Search

Biology subjects

Lemiere, S.

Publications and source records attributed to Lemiere, S..

2 recordsLinked to original sources

Bone Material Properties Distributions from quantitative Raman analysis: a distribution-based approach to human bone matrix characterization

Background: Bone mechanical competence depends not only on bone mass but also on the spatial organization of mineral and organic matrix properties. Whereas quantitative backscattered electron imaging (qBEI) characterizes mineral heterogeneity using Bone Mineral Density Distributions (BMDDs), no equivalent framework currently exists for describing the biochemical heterogeneity of the bone matrix by Raman microspectroscopy. Methods: We developed a quantitative Raman analysis (qRA) workflow to generate Bone Material Properties Distributions (BMPDs). Raman spectra were acquired along full-thickness line scans crossing successive bone structural units in human trabecular and cortical bone. Pixel-wise Raman-derived biochemical parameters describing collagen organization, advanced glycation end-products, glycosaminoglycans, mineral-to-matrix ratios, carbonate substitution, and mineral crystallinity were converted into normalized frequency distributions and modeled using gaussian functions. BMPDs were generated from undecalcified pMMA-embedded iliac biopsies (n=38) and routinely processed decalcified paraffin-embedded osteomedullary biopsies (n=21). The analytical framework was validated against conventional two-dimensional Raman mapping, and reproducibility, interindividual variability, and demographic influences were evaluated. Results: BMPDs were consistently well described by gaussian functions (typically R2 > 0.95), allowing extraction of three descriptors for each biochemical parameters: Mean, Peak, and Width. One-dimensional line scans showed excellent agreement with conventional two-dimensional Raman mapping while reducing acquisition time approximately 100-fold. Technical variability remained substantially lower than biological variability for all parameters, and a single trabecular line scan provided reliable estimates of BMPD descriptors for nearly all Raman-derived indices. Cortical bone exhibited narrower BMPDs than trabecular bone, indicating lower biochemical heterogeneity. Comparable BMPDs were obtained from undecalcified and routinely decalcified specimens, demonstrating robustness to tissue processing. No significant associations with age or sex were observed after correction for multiple testing. Reference BMPDs further enabled visualization and standardized quantification of deviations in representative pathological bone biopsies. Conclusions: Quantitative Raman analysis introduces BMPDs as a novel framework for assessing the spatial heterogeneity of bone extracellular matrix composition. By extending Raman microspectroscopy beyond conventional mean measurements, BMPDs provide robust, reproducible descriptors of bone material organization and establish a methodological foundation for investigating alterations of bone quality in metabolic bone diseases.

physiology↗

Hypertrophic bone proliferation at enthesis induced by unilateral injection of botulinum toxin in masticatory muscles in adult rats is characterized by chondrocyte proliferation without inflammatory process at enthesis

A single injection of botulinum toxin injected in masticatory muscles induces alveolar bone loss associated with muscle enthesis hypertrophic bone proliferation. The tissular and cellular mechanisms involved in this phenomenon are unknown. Because new bone formation due to inflammation at enthesis is observed in articular disorder like spondyloarthritis, we hypothesize that an inflammatory process could explain the development of hypertrophic bone proliferation in the BTX model. The aims of the study were to test this hypothesis and to determine whether IL-17A was involved. Mature Sprague-Dawley male rats (n=36) were randomized into 4 groups. Three groups received BTX injections in right masseter and temporalis muscle. One BTX group was treated with an anti-IL17A antibody for 31 days (BTX31+antiIL17A). The two other groups were respectively sacrificed at 21 (BTX21) and 31 (BTX31) days post BTX injection. The remaining non-BTX group received anti-IL17A treatment for 31 days (control+anti-IL-17A). Alveolar bone loss and hypertrophic bone proliferation at enthesis were studied using microcomputed tomography. The presence of inflammatory process and the implication of IL17A was assessed by histology and immunohistochemistry on decalcified right side hemimandibles. Quantitative measurement of the hypertrophic bone (bone volume and thickness) showed no significant differences between the 3 BTX groups. Histology revealed the presence of chondrocytes in large hypertrophic area but no inflammatory infiltrated cells. Immunochemistry confirmed the absence of inflammatory process but positive reaction for Ki67 which is in favor of actively growing and proliferative chondrocytes. BTX-related muscle atrophy of masticatory muscle induced chondrocyte proliferation at enthesis without inflammation process.

pathology↗